4.4 Article

Patient research priority setting partnership in human T-cell lymphotropic virus type I

Related references

Note: Only part of the references are listed.
Article Neurosciences

Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers

Daniel Harding et al.

Summary: This study found that markers of T cell activation and beta(2)-microglobulin in the blood can identify asymptomatic carriers of HTLV-1 who are at higher risk of developing HTLV-1-associated myelopathy. The method correctly identified 88% of patients with HTLV-1-associated myelopathy and 6% of asymptomatic carriers.

JOURNAL OF NEUROVIROLOGY (2022)

Article Public, Environmental & Occupational Health

Spirituality as Strategies for Coping With Tropical Spastic Paraparesis: Results of Focus Group

Amine Lopes Benevides et al.

Summary: This study found that spirituality can help people with HAM/TSP cope with disability and pain, which is not limited to religious practices, but also includes emotions and trust in God.

JOURNAL OF RELIGION & HEALTH (2022)

Review Pharmacology & Pharmacy

An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers

Junji Yamauchi et al.

Summary: HAM/TSP is a rare inflammatory disease that causes unremitting and progressive neurological disorders. Immune-modulating agents are used to slow disease progression, but the lack of surrogate biomarkers hampers clinical trials and the assessment of treatment efficacy. The identification of biomarkers associated with viral components or inflammatory mediators is crucial for improving patient care and developing therapies for HAM/TSP.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Neurosciences

Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study

Dislene Nascimento dos Santos et al.

Summary: Individuals infected with HTLV-1 experience higher intensity pain, with different pain characteristics and impact on quality of life compared to chronic pain patients. Characteristics vary between subgroups, with oligosymptomatic and HAM/TSP individuals showing more severe pain features and greater impact on quality of life. Inflammatory cytokine levels are elevated in HTLV-1-related pain.

JOURNAL OF NEUROVIROLOGY (2021)

Article Parasitology

Therapeutic effects of virtual reality video gaming on functional mobility, balance, and gait speed in individuals with tropical spastic paraparesis: A randomized crossover clinical trial

Erika Pedreira da Fonseca et al.

Summary: This study demonstrates the therapeutic effects of VR video games on functional mobility, balance, and gait speed in individuals with HAM/TSP. Patients who received early therapy showed improvements in BBS scores, TUG times, and gait speed compared to those who started therapy later.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2021)

Article Health Care Sciences & Services

Signs, meanings and practices of people living with human t-cell lymphotropic virus type 1 or tropical spastic myelopathy

Genildes Oliveira Santana et al.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2020)

Article Neurosciences

Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1)

Roberta Vilela Lopes Koyama et al.

JOURNAL OF NEUROVIROLOGY (2019)

Review Medicine, Research & Experimental

A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies

Olivier Hermine et al.

ADVANCES IN THERAPY (2018)

Review Health Care Sciences & Services

Physiotherapy for human T-lymphotropic virus I -associated myelopathy: review of the literature and future perspectives

Katia N. Sa et al.

JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2015)

Review Oncology

Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma

Kenji Ishitsuka et al.

LANCET ONCOLOGY (2014)

Article Infectious Diseases

Living Invisible: HTLV-1-Infected Persons and the Lack of Care in Public Health

Karina Franco Zihlmann et al.

PLOS NEGLECTED TROPICAL DISEASES (2012)

Article Clinical Neurology

A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK

Fabiola Martin et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Review Infectious Diseases

Human T-lymphotropic virus 1: recent knowledge about an ancient infection

Kristien Verdonck et al.

LANCET INFECTIOUS DISEASES (2007)

Article Medicine, General & Internal

HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests

JHC Tosswill et al.

BRITISH MEDICAL JOURNAL (2000)